Condition
E Coli Infection
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Recruiting1
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07318584Phase 2Not Yet RecruitingPrimary
Cefotetan Therapy for Escherichia Coli Infections
NCT06148480RecruitingPrimary
Perinatal Transmission of MDR Bacteria
NCT04694235Not ApplicableActive Not Recruiting
Egg Intervention During Pregnancy in Indonesia
NCT04117113CompletedPrimary
Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2)
NCT04574596CompletedPrimary
Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli
NCT00298103CompletedPrimary
Antibiotic Resistant Community-Acquired E. Coli
Showing all 6 trials